title: Atrial natriuretic peptide suppresses osmostimulated vasopressin release in young and elderly humans.
abstract: Atrial natriuretic peptide (ANP) may suppress vasopressin release, but the dynamics of this interaction as well as the influence of age have not been defined. We studied six or seven young (19-40 yr old) and seven elderly volunteers (65-83 yr old) under two circumstances: 1) after infusion of 5% saline (0.04 ml.kg-1.min-1) for 2 h and 2) after the same infusion given with simultaneous synthetic human ANP (0.05 micrograms.kg-1.min-1). Hypertonic saline alone produced a progressive rise in plasma vasopressin with increasing serum sodium. During hypertonic saline alone, vasopressin levels began to rise at an increment in serum sodium of 1.67 +/- 0.35 mM in the young and 1.43 +/- 0.32 mM in the elderly and rose linearly with increasing serum sodium. When ANP was infused with hypertonic saline (with peak ANP levels of approximately 1,000 pM), vasopressin levels began to rise at an increment in serum sodium of 4.43 +/- 0.67 mM in the young and 4.57 +/- 0.43 mM in the elderly (P less than 0.01 vs. saline alone). Furthermore, the vasopressin response for any given serum sodium was significantly reduced in both young and elderly subjects, resulting in a rightward displacement of the curve relating vasopressin response to sodium concentration (P less than 0.001). In conclusion, ANP not only suppresses vasopressin but raises the threshold for release of vasopressin in response to osmotic stimulation in both young and elderly individuals. High circulating ANP levels may be responsible in part for the suppression of vasopressin levels and water diuresis seen during states of volume expansion.
authors.affiliation: Charles A. Dana Research Institute, Beth Israel Hospital, Department of Medicine, Boston, Massachusetts.
authors.forename: B A
authors.initials: BA
authors.lastname: Clark
authors.forename: D
authors.initials: D
authors.lastname: Elahi
authors.forename: L
authors.initials: L
authors.lastname: Fish
authors.forename: M
authors.initials: M
authors.lastname: McAloon-Dyke
authors.forename: K
authors.initials: K
authors.lastname: Davis
authors.forename: K L
authors.initials: KL
authors.lastname: Minaker
authors.forename: F H
authors.initials: FH
authors.lastname: Epstein
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000378:metabolism*; D009320:Atrial Natriuretic Factor / Q000097:blood / Q000494:pharmacology*; D001794:Blood Pressure; D006801:Humans; D008297:Male; D009994:Osmolar Concentration; D012462:Saline Solution, Hypertonic / Q000494:pharmacology; D014667:Vasopressins / Q000378:metabolism*
chemical_list: D012462:Saline Solution, Hypertonic; D014667:Vasopressins; D009320:Atrial Natriuretic Factor